Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Mar 19, 16:01
897.35 -7.75 (-0.86%)
Volume
AVERAGE VOLUME
5-Day
10,197
10-Day
7,514
30-Day
6,352
4,163
  • Prev. Close

    905.10

  • Open Price

    890.05

  • Bid Price (Qty.)

    890.00 (100)

  • Offer Price (Qty.)

    912.00 (10)

NSE Live

Mar 19, 15:59
897.60 -9.45 (-1.04%)
Volume
AVERAGE VOLUME
5-Day
295,451
10-Day
259,578
30-Day
220,556
253,848
  • Prev. Close

    907.05

  • Open Price

    895.00

  • Bid Price (Qty.)

    897.60 (546)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Balance Sheet of Strides Pharma Science (in Rs. Cr.) Dec 09 Dec 08 Dec 07 Dec 06 Dec 05  
  12 mths 12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 40.22 40.05 35.00 34.95 34.95  
Total Share Capital 89.38 89.21 84.17 84.12 84.12  
Reserves and Surplus 820.95 289.73 160.80 278.47 253.62  
Total Reserves and Surplus 820.95 289.73 160.80 278.47 253.62  
Total Shareholders Funds 910.33 378.94 244.97 362.58 337.74  
NON-CURRENT LIABILITIES  
Long Term Borrowings 929.44 829.47 848.79 236.63 254.73  
Deferred Tax Liabilities [Net] 0.00 5.85 7.95 14.62 10.95  
Other Long Term Liabilities 0.00 0.00 0.00 0.00 0.00  
Long Term Provisions 0.00 0.00 0.00 0.00 0.00  
Total Non-Current Liabilities 929.44 835.32 856.74 251.25 265.68  
CURRENT LIABILITIES  
Short Term Borrowings 302.80 267.99 213.98 95.65 63.68  
Trade Payables 212.49 164.96 168.71 128.36 74.85  
Other Current Liabilities 8.14 33.64 63.80 5.52 10.47  
Short Term Provisions 169.55 70.92 29.27 31.55 25.83  
Total Current Liabilities 692.97 537.50 475.76 261.08 174.83  
Total Capital And Liabilities 2,550.35 1,753.56 1,596.45 910.35 781.82  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 201.87 152.21 157.54 152.34 116.93  
Intangible Assets 125.02 9.06 8.01 9.52 9.14  
Capital Work-In-Progress 11.21 145.41 50.46 37.98 44.68  
Other Assets 0.00 0.00 0.00 0.00 0.00  
Fixed Assets 338.11 306.67 216.01 199.85 170.75  
Non-Current Investments 1,518.04 939.58 590.32 298.29 233.45  
Deferred Tax Assets [Net] 0.00 0.00 0.00 0.00 0.00  
Long Term Loans And Advances 0.00 0.00 0.00 0.00 0.00  
Other Non-Current Assets 0.00 0.00 0.00 0.00 0.00  
Total Non-Current Assets 1,856.15 1,246.25 806.34 498.14 404.20  
CURRENT ASSETS  
Current Investments 0.00 0.00 0.00 0.00 0.00  
Inventories 95.50 86.97 72.21 63.83 50.28  
Trade Receivables 207.53 208.44 180.22 166.93 120.62  
Cash And Cash Equivalents 31.38 16.38 125.59 15.74 77.75  
Short Term Loans And Advances 359.79 195.51 166.25 154.27 91.96  
OtherCurrentAssets 0.00 0.00 245.85 11.45 37.02  
Total Current Assets 694.20 507.31 790.11 412.21 377.62  
Total Assets 2,550.35 1,753.56 1,596.45 910.35 781.82  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 163.25 212.57 192.61 309.54 141.94  
CIF VALUE OF IMPORTS  
Raw Materials 159.93 111.72 72.82 80.19 59.16  
Stores, Spares And Loose Tools 0.00 0.00 0.00 0.00 0.00  
Trade/Other Goods 0.00 0.00 0.00 0.00 0.00  
Capital Goods 12.91 43.26 26.57 25.65 18.69  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 24.07 21.91 27.20 14.66 21.37  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- -- 2.77 -- 1.90  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods 545.22 462.90 322.21 396.49 287.71  
Other Earnings 84.72 115.00 61.04 37.12 50.69  
BONUS DETAILS  
Bonus Equity Share Capital 1.25 1.25 1.25 1.25 1.25  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value -- -- -- -- --  
Non-Current Investments Unquoted Book Value 1,602.35 1,021.11 836.17 309.74 270.46  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value -- -- -- -- --  
Current Investments Unquoted Book Value -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347